CD40 stimulation sensitizes CLL cells to rituximab-induced cell death

被引：25

作者：

Jak, M. ^{[1
,2
]}

van Bochove, G. G. W. ^{[1
]}

van Lier, R. A. W. ^{[2
]}

Eldering, E. ^{[2
]}

van Oers, M. H. J. ^{[1
]}

机构：

[1] Univ Amsterdam, Acad Med Ctr, Dept Hematol, NL-1105 AZ Amsterdam, Netherlands

[2] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands

来源：

LEUKEMIA | 2011年 / 25卷 / 06期

关键词：

chronic lymphocytic leukemia; anti-CD20; cell death; CD40; stimulation; CHRONIC LYMPHOCYTIC-LEUKEMIA; B-CELLS; MONOCLONAL-ANTIBODY; DOWN-REGULATION; HLA-DR; CD20; APOPTOSIS; LYMPHOMA; EXPRESSION; KINASE;

D O I：

10.1038/leu.2011.39

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

In vitro CD40-stimulated chronic lymphocytic leukemia (CLL) cells are resistant to cytotoxic drugs. In sharp contrast, we here show that CD40 stimulation sensitizes CLL cells to rituximab-mediated cell death. This increased sensitivity is specific for anti-CD20 treatment. Rituximab-mediated death in CD40-stimulated CLL cells shows rapid kinetics (within hours), and is caspase and p53 independent, but depends on extracellular Ca2+ and reactive oxygen species (ROS) production. By increasing basal ROS production, CD40 stimulation sensitizes CLL cells to rituximab-mediated death. Our findings provide a rationale for combination treatment of CLL with cytotoxic drugs and anti-CD20 monoclonal antibodies. Leukemia (2011) 25, 968-978; doi:10.1038/leu.2011.39; published online 15 March 2011

引用

页码：968 / 978

页数：11

共 60 条

[21]

2-Y

[22] Levels of expression of CD19 and CD20 in chronic B cell leukaemias [J].

Ginaldi, L ;

De Martinis, M ;

Matutes, E ;

Farahat, N ;

Morilla, R ;

Catovsky, D .

JOURNAL OF CLINICAL PATHOLOGY, 1998, 51 (05) :364-369

[23] Mechanisms of killing by anti-CD20 monoclonal antibodies [J].

Glennie, Martin J. ;

French, Ruth R. ;

Cragg, Mark S. ;

Taylor, Ronald P. .

MOLECULAR IMMUNOLOGY, 2007, 44 (16) :3823-3837

[24] CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59 [J].

Golay, J ;

Lazzari, M ;

Facchinetti, V ;

Bernasconi, S ;

Borleri, G ;

Barbui, T ;

Rambaldi, A ;

Introna, M .

BLOOD, 2001, 98 (12) :3383-3389

[25]

Golay J, 2003, HAEMATOLOGICA, V88, P1002

[26] Cell death by necrosis: towards a molecular definition [J].

Golstein, Pierre ;

Kroemer, Guido .

TRENDS IN BIOCHEMICAL SCIENCES, 2007, 32 (01) :37-43

[27] Influence of CD40 ligation on apoptosis of B-CLL cells survival and in vitro [J].

Grdisa, M .

LEUKEMIA RESEARCH, 2003, 27 (10) :951-956

[28] Mitochondrial calcium signalling and cell death:: Approaches for assessing the role of mitochondrial Ca2+ uptake in apoptosis [J].

Gyorgy Hajnoczky ;

Gyrogy Csordas ;

Das, Sudipto ;

Garcia-Perez, Cecilia ;

Saotome, Masao ;

Roy, Soumya Sinha ;

Yi, Muqing .

CELL CALCIUM, 2006, 40 (5-6) :553-560

[29] Crosstalk among Bcl-2 family members in B-CLL: seliciclib acts via the Mcl-1/Noxa axis and gradual exhaustion of Bcl-2 protection [J].

Hallaert, D. Y. H. ;

Spijker, R. ;

Jak, M. ;

Derks, I. A. M. ;

Alves, N. L. ;

Wensveen, F. M. ;

de Boer, J. P. ;

de Jong, D. ;

Green, S. R. ;

van Oers, M. H. J. ;

Eldering, E. .

CELL DEATH AND DIFFERENTIATION, 2007, 14 (11) :1958-1967

[30] c-Abl kinase inhibitors overcome CD40-mediated drug resistance in CLL: implications for therapeutic targeting of chemoresistant niches [J].

Hallaert, Delfine Y. H. ;

Jaspers, Annelieke ;

van Noesel, Carel J. ;

van Oers, Marinus H. J. ;

Kater, Arnon P. ;

Eldering, Eric .

BLOOD, 2008, 112 (13) :5141-5149

← 1 2 3 4 5 6 →